Arcadia Biosciences Inc.

NASDAQ: RKDA · Real-Time Price · USD
4.41
-0.22 (-4.75%)
At close: Aug 14, 2025, 3:40 PM
4.55
3.17%
After-hours: Aug 14, 2025, 06:21 PM EDT

Arcadia Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
5.04M 5.33M 9.96M 6.78M
Cost of Revenue
2.96M 3.3M 9.8M 8.71M
Gross Profit
2.08M 2.03M 154K -1.93M
Operating Income
-3.65M -13.87M -19.4M -35.53M
Interest Income
782K 695K 289K n/a
Pretax Income
-4.31M -13.16M -15.6M -16.13M
Net Income
-7.04M -13.98M -15.61M -16.13M
Selling & General & Admin
9.64M 14.51M 18.05M 22.94M
Research & Development
53K 1.39M 1.51M 3.89M
Other Expenses
-3.96M n/a 33K n/a
Operating Expenses
5.73M 15.89M 19.56M 26.83M
Interest Expense
n/a n/a n/a 20K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
12.66M 19.2M 29.36M 35.53M
Income Tax Expense
8K 8K 14K 2K
Shares Outstanding (Basic)
1.36M 1.24M 599.39K 532.01K
Shares Outstanding (Diluted)
1.36M 1.24M 599.39K 532.01K
EPS (Basic)
-5.16 -11.3 -26.05 -30.33
EPS (Diluted)
-5.16 -11.3 -26.05 -30.33
EBITDA
-7.5M -13.58M -13.65M -23.27M
EBIT
-7.61M -13.16M -15.23M -28.75M
Depreciation & Amortization
n/a 287K 1.36M 1.04M